Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2010 Dec 3;4(1):49–55. doi: 10.1161/CIRCEP.110.959957

Table 1.

Baseline Patient Characteristics

No Age (yrs) Sex LVEF,% AAD Before Procedure # Prior Procedures Clinical Arrhythmia ICD Present
EPI-(Group 1)
1 26 M 55 Flecainide 1 SMVT No
2 31 M 55 None 0 SMVT No
3 19 F 65 None 2 SMVT No
4 47 M 50 Sotalol 0 PVC No
5 53 F 65 None 1 PVC No

EPI+ (Group 2)
1 51 F 30 Lido+Proc 0 SMVT Yes
2 48 M 45 Amiodarone 0 SMVT Yes
3 53 M 50 Sotalol+Mex 0 SMVT Yes
4 48 M 45 Propafenone 3 SMVT Yes
5 73 M 25 Amiodarone 1 SMVT Yes
6 26 M 60 None 1 SMVT No
7 51 M 30 Amiodarone 1 SMVT Yes
8 27 F 20 Dofet+Mex 0 SMVT Yes
9 39 M 55 Amiodarone 1 SMVT Yes
10 52 M 50 Amiodarone 1 SMVT Yes
11 58 M 50 Amio+Quin 0 SMVT No
*

AAD: antiarrhythmic drugs EF: ejection fraction; F: female; M: male; PVC: premature ventricular complex; SMVT: sustained monomorphic ventricular tachycardia.